Solo Brands (DTC) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
10 Apr, 2026Executive summary
Annual meeting scheduled for May 22, 2026, with virtual participation available to shareholders.
Shareholders are encouraged to review proxy materials and vote by May 21, 2026.
Voting matters and shareholder proposals
Election of two directors: Paul Furer and Peter Laurinaitis, with board recommending approval.
Ratification of BDO USA, P.C. as independent auditor for fiscal year ending December 31, 2026.
Approval of the Amended and Restated 2021 Incentive Award Plan.
Approval to adjourn the meeting if more time is needed to solicit votes for Proposal 3.
Additional business may be transacted as appropriate during the meeting.
Board of directors and corporate governance
Board recommends all proposals, including director nominees and incentive plan changes.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Solo Brands
- Annual meeting to vote on directors, auditor, incentive plan, and adjournment; board recommends approval.DTC
Proxy filing10 Apr 2026 - Disciplined cost actions and innovation drive profit-focused growth and global expansion.DTC
38th Annual Roth Conference Presentation31 Mar 2026 - Cost cuts, innovation, and margin discipline drove improved cash flow amid steep sales declines.DTC
Q4 202519 Mar 2026 - Turnaround strategy targets growth in 2025 through innovation, retail, and operational excellence.DTC
2024 Southwest IDEAS Conference3 Feb 2026 - Turnaround plan, cost cuts, and new products set stage for growth after a tough 2024.DTC
16th Annual Midwest Ideas Conference3 Feb 2026 - Aggressive cost cuts, innovation, and retail realignment drive recovery amid tough headwinds.DTC
17th Annual Southwest IDEAS Conference3 Feb 2026 - Retail gains offset DTC softness, but higher costs and soft demand led to a Q2 net loss.DTC
Q2 20242 Feb 2026 - Q3 net loss of $111.5M on 14.7% lower sales, with major restructuring and guidance reaffirmed.DTC
Q3 202416 Jan 2026 - Turnaround plan and leadership changes follow sales drop and liquidity concerns.DTC
Q4 202424 Dec 2025